tiprankstipranks
Sonnet BioTherapeutics Holdings (SONN)
NASDAQ:SONN
US Market

Sonnet BioTherapeutics Holdings (SONN) Ownership - Who Owns Sonnet BioTherapeutics Holdings?

416 Followers

Sonnet BioTherapeutics Holdings (SONN) Ownership Overview

33.23%0.77%0.82%65.18%
33.23% Insiders
0.82% Other Institutional Investors
65.18% Public Companies and
Individual Investors
The ownership structure of Sonnet BioTherapeutics Holdings (SONN) stock is a mix of institutional, retail and individual investors. Approximately 1.59% of the company’s stock is owned by Institutional Investors, 33.23% is owned by Insiders and 65.18% is owned by Public Companies and Individual Investors.
The ownership structure of Sonnet BioTherapeutics Holdings (SONN) stock is a mix of institutional, retail and individual investors. Approximately 1.59% of the company’s stock is owned by Institutional Investors, 33.23% is owned by Insiders and 65.18% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Currently, No Data Available
Date
Name
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
38,637Insider1.24%34,001
26,971Insider0.87%23,734
18,100Insider0.58%15,928
17,246Insider0.55%15,176
16,500Insider0.53%14,520
14,726Institution0.47%12,959
14,726Institution0.47%12,959
14,663Insider0.47%12,903
9,159Institution0.29%8,060
811Insider0.03%714

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
14,726Institution0.47%12,959
9,159Institution0.29%8,060

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
14,726Institution0.47%23,120

FAQ

Who Owns Sonnet BioTherapeutics Holdings (SONN)?
According to the latest TipRanks data, approximately 0.82% of the company's stock is held by institutional investors, 33.23% is held by insiders, and 65.18% is held by retail investors.
    What percentage of Sonnet BioTherapeutics Holdings (SONN) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.82% of Sonnet BioTherapeutics Holdings (SONN) stock is held by institutional investors.
      What percentage of Sonnet BioTherapeutics Holdings (SONN) stock is held by retail investors?
      According to the latest TipRanks data, approximately 65.18% of Sonnet BioTherapeutics Holdings (SONN) stock is held by retail investors.
        Who owns the most shares of Sonnet BioTherapeutics Holdings (SONN)?
        Keith J. Johnson owns the most shares of Sonnet BioTherapeutics Holdings (SONN).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis